{"prompt": "['G.O.N.O.', 'GRUPPO ONCOLOGICO DEL NORD OVEST', 'TITLE:', 'The CONFRONT Phase I - II Trial: ACtivatiON oF immune Response in paTients with R-M', 'Head and Neck Cancer. Multimodality immunotherapy with Avelumab, short course radiotherapy', 'and Cyclophosphamide in Head and Neck cancer.', 'EudraCT n. 2017-000353-39', '1. PI Marco Carlo Merlano', '2. Institution G.O.N.O Gruppo Oncologico Nord Ovest', '3. Contact Info:', 'Principal Investigator', 'MERLANO MARCO CARLO', 'memerlano@gmail.com, merlano.m@ospedale.cuneo.it', 'Oncology Department AO Santa Croce E Carle', 'Via Michele Coppino 26', '12100 Cuneo Italy', '+390171616739', 'Fax +390171616737', 'CONFRONT Study v. 1.1 del 07052018 - Study Protocol']['Coinvestigators', 'NERINA DENARO', 'herinadenaro@gmail.com', 'Oncology Department AO Santa Croce e Carle Via Michele Coppino 26', '12100 Cuneo Italy', '+390171616350', 'Fax +390171616737', 'ELVIO GRAZIOSO RUSSI', 'elviorussi@gmail.com', 'Oncology Department AO Santa Croce e Carle Via Michele Coppino 26', '12100 Cuneo Italy', '+390171616739', 'Fax +390171616737', 'ELENA FEA', 'fea.e@ospedale.cuneo.it', 'Oncology Department AO Santa Croce e Carle Via Michele Coppino 26', '12100 Cuneo Italy', '+390171616350', 'Fax +390171616737', 'ANNAMARIA MERLOTTI', 'merlotti.a@ospedale.cuneo.it', 'Radiotherapy Department AO Santa Croce e Carle Via Michele Coppino 26', '12100 Cuneo Italy', '+390171616739', 'Fax +390171616737', 'CONFRONT Study V. 1.1 del 07/05/2018 - Study Protocol', '1']['INVESTIGATOR AGREEMENT', 'I have read the Protocol entitled The CONFRONT Phase I - II Trial: ACtivatiON oF immune', 'RespONse in paTients with R-M Head and Neck Cancer. Multimodality immunotherapy with', 'Avelumab, short course radiotherapy and Cyclophosphamide in Head and Neck cancer and I agree to', 'conduct the study as detailed herein and in compliance with ICH Guidelines for good clinical', 'Practice and applicable regulatory requirements.', \"Prineipa/Navestigator's Signature\", 'Palic', 'May 7th 2018', 'Dr. Marco Carlo Merlano', 'Date', 'PARTICIPATING SITE PRINCIPAL INVESTIGATOR', 'Dr.', 'Signature', 'CONFRONT Study v. 1.1 del 07/05/2018 - Study Protocol', '2']\n\n###\n\n", "completion": "END"}